Padlock Therapeutics investors accused Bristol Myers of avoiding making milestone payments promised under a 2016 deal.
Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback